Literature DB >> 1125840

Fibrillopathia epitheliocapsularis (pseudoexfoliation): a clinical and electron microscope study.

D H Dickson, M S Ramsay.   

Abstract

The light microscopic and transmission and scanning electron microscopic findings from two cases of fibrillopathia epitheliocapsularis (pseudoexfoliation) are presented. The ciliary processes, posterior iris and preequatiorial lens capsule were found to be covered with a fine, white, flocculent material. Light microscopic examination revealed feathery, eosinophilic deposits on all three tissues; electron microscope studies showed the exfoilative deposits to be composed of a fine meshwork of fibrils ranging in size from 200-300 A. Fibrils were found on the apical surfaces of the epithelial cells, as well as on and throughout the epithelial cell basement membranes. The general distribution and possible sources of the pseudoexfoilative material are discussed with respect to other recent investigations. The value of the scanning electron microscope as a tool in pathological studies is presented.

Entities:  

Mesh:

Year:  1975        PMID: 1125840

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  4 in total

1.  Pseudoexfoliative disease of the lens: a study in electron microscopy and histochemistry.

Authors:  A J Dark; B W Streeten; C C Cornwall
Journal:  Br J Ophthalmol       Date:  1977-07       Impact factor: 4.638

2.  Exfoliation syndrome and occludable angles.

Authors:  R Ritch
Journal:  Trans Am Ophthalmol Soc       Date:  1994

3.  Factors in the exfoliation syndrome.

Authors:  J G Madden; M J Crowley
Journal:  Br J Ophthalmol       Date:  1982-07       Impact factor: 4.638

4.  Transmission electron microscopy study of undescribed material at the anterior lens capsule in exfoliation syndrome.

Authors:  Konstantina N Sorkou; Maria-Eleni Manthou; Konstantinos T Tsaousis; Periklis Brazitikos; Ioannis T Tsinopoulos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-07       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.